KUWAIT CANCER CONTROL CENTER
🇰🇼Kuwait
Clinical Trials
3
Active:0
Completed:0
Trial Phases
2 Phases
Phase 2:1
Phase 3:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 3
2 (66.7%)Phase 2
1 (33.3%)Induction Versus Adjuvant Gemcitabine/Cisplatin in Locally Advanced Non-metastatic Nasopharyngeal Carcinoma
Phase 3
Recruiting
- Conditions
- Nasopharyngeal Carcinoma
- Interventions
- Drug: Gemcitabin/cisplatin
- First Posted Date
- 2021-05-24
- Last Posted Date
- 2022-08-17
- Lead Sponsor
- Kuwait Cancer Control Center
- Target Recruit Count
- 120
- Registration Number
- NCT04898374
- Locations
- 🇰🇼
Kuwait Cancer Control Center, Kuwait, Kuwait
EBV Positive Nasopharyngeal Carcinoma Treated With Concurrent Chemo-radiotherapy With or Without Anti-Viral Drug
Phase 3
- Conditions
- Drug Use for Unapproved Schedule
- Interventions
- Combination Product: Radiotherapy and chemotherapy
- First Posted Date
- 2018-09-04
- Last Posted Date
- 2018-09-04
- Lead Sponsor
- Kuwait Cancer Control Center
- Target Recruit Count
- 50
- Registration Number
- NCT03656965
- Locations
- 🇰🇼
Kuwait Cancer Control Center, Kuwait, Kuwait
Concomitant Immune Check Point Inhibitor With Radiochemotherapy in Head And Neck Cancer
- First Posted Date
- 2018-05-22
- Last Posted Date
- 2024-01-23
- Lead Sponsor
- Kuwait Cancer Control Center
- Target Recruit Count
- 50
- Registration Number
- NCT03532737
- Locations
- 🇰🇼
Kuwait Cancer Control Center, Kuwait, Kuwait
News
No news found